• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma.

作者信息

Roche Nicolas, Postma Dirkje S, Colice Gene, Burden Anne, Guilbert Theresa W, Israel Elliot, Martin Richard J, van Aalderen Willem M C, Grigg Jonathan, Hillyer Elizabeth V, von Ziegenweidt Julie, Price David B

机构信息

1 Cochin Hospital Group AP-HP Paris, France.

出版信息

Am J Respir Crit Care Med. 2015 Apr 15;191(8):960-4. doi: 10.1164/rccm.201411-2116LE.

DOI:10.1164/rccm.201411-2116LE
PMID:25876207
Abstract
摘要

相似文献

1
Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma.吸入性糖皮质激素对吸烟/戒烟者和非吸烟哮喘患者的不同影响。
Am J Respir Crit Care Med. 2015 Apr 15;191(8):960-4. doi: 10.1164/rccm.201411-2116LE.
2
Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.与非超细颗粒吸入性皮质类固醇相比，在哮喘的吸烟者和戒烟者中。
Respir Med. 2017 Sep;130:35-42. doi: 10.1016/j.rmed.2017.07.005. Epub 2017 Jul 8.
3
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.比较小颗粒与大颗粒吸入性糖皮质激素在慢性阻塞性肺疾病中的疗效。
Int J Chron Obstruct Pulmon Dis. 2014 Oct 17;9:1163-86. doi: 10.2147/COPD.S68289. eCollection 2014.
4
Treatment of eosinophilic esophagitis with inhaled corticosteroids.吸入性糖皮质激素治疗嗜酸性粒细胞性食管炎
J Pediatr Gastroenterol Nutr. 1998 Jul;27(1):90-3. doi: 10.1097/00005176-199807000-00016.
5
[How to make easier the treatment of asthma].[如何使哮喘治疗更简便]
Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S76-10S79.
6
Inhaled corticosteroid therapy in asthma: a balancing act.哮喘的吸入性糖皮质激素治疗：一种权衡之举。
Ann Allergy Asthma Immunol. 1999 Mar;82(3):229-30. doi: 10.1016/S1081-1206(10)62602-6.
7
Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma.超细氢氟烷烃倍氯米松与氟替卡松干粉吸入器对儿童哮喘呼出炎症标志物抗炎作用的比较。
Ann Allergy Asthma Immunol. 2008 Jun;100(6):601-7. doi: 10.1016/S1081-1206(10)60052-X.
8
[A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].与丙酸倍氯米松和孟鲁司特联合使用相比，氟替卡松和沙美特罗的固定组合能更好地控制哮喘。
Eur Ann Allergy Clin Immunol. 2003 Nov;35(9):356-62.
9
Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.哮喘中的资源利用：丙酸氟替卡松/沙美特罗联合用药与吸入性糖皮质激素的比较
Curr Med Res Opin. 2007 Feb;23(2):427-34. doi: 10.1185/030079906X167417.
10
[Treatment compliance in asthma: a Tunisian transversal study].[哮喘的治疗依从性：一项突尼斯横断面研究]
Tunis Med. 2005 Aug;83(8):448-52.

引用本文的文献

1
Corticosteroid Resistance in Smokers-A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial.吸烟者的皮质类固醇抵抗——CORTICO-COP随机对照试验的一项子研究分析
J Clin Med. 2021 Jun 21;10(12):2734. doi: 10.3390/jcm10122734.
2
Efficacy of indacaterol/glycopyrronium salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials.茚达特罗/格隆溴铵与沙美特罗/氟替卡松在当前吸烟者和既往吸烟者中的疗效：IGNITE试验的汇总分析。
ERJ Open Res. 2021 Feb 22;7(1). doi: 10.1183/23120541.00816-2020. eCollection 2021 Jan.
3
Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.
呼吸领域真实世界有效性研究的质量标准：真实生活证据评估工具（RELEVANT）：来自呼吸有效性研究组-欧洲变态反应与临床免疫学会特别工作组的报告
Clin Transl Allergy. 2019 Mar 27;9:20. doi: 10.1186/s13601-019-0255-x. eCollection 2019.
4
The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship.二肽基肽酶-4抑制剂对哮喘控制的影响：一项评估潜在病理生理关系的管理数据库研究
Pragmat Obs Res. 2017 Dec 1;8:231-240. doi: 10.2147/POR.S144018. eCollection 2017.
5
Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study.吸入器装置的自付费用是否会影响治疗依从性和疾病结局？一项历史性匹配队列研究。
Pragmat Obs Res. 2017 Apr 18;8:31-41. doi: 10.2147/POR.S132658. eCollection 2017.
6
Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids.开始使用超细环索奈德或细颗粒吸入性糖皮质激素的患者的哮喘相关转归
Allergy Asthma Immunol Res. 2017 Mar;9(2):116-125. doi: 10.4168/aair.2017.9.2.116.
7
Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma.年龄和疾病严重程度对哮喘患者全身皮质类固醇反应的影响。
Am J Respir Crit Care Med. 2017 Jun 1;195(11):1439-1448. doi: 10.1164/rccm.201607-1453OC.
8
2016 Respiratory Effectiveness Group Annual Summit Report-impact & influence of real-world respiratory evidence.2016年呼吸有效性小组年度峰会报告——真实世界呼吸证据的影响
J Thorac Dis. 2016 Jul;8(Suppl 5):S435-44. doi: 10.21037/jtd.2016.07.16.
9
Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians.确立吸入器满意度、治疗依从性与患者治疗效果之间的关系：一项针对美国成年哮喘患者及医生的前瞻性、真实世界横断面调查。
World Allergy Organ J. 2015 Sep 10;8(1):26. doi: 10.1186/s40413-015-0075-y. eCollection 2015.